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Background. Infection with human papilloma- 
virus (HPV) is considered to be the principal causal agent 
in the development of squamous cell carcinoma of the 
uterine cervix. Although adenocarcinoma of the cervix 
originates adjacent to the squamous epithelial neoplastic 
lesions, the etiopathogenesis of adenocarcinoma is not 
yet clearly understood. Recent studies have raised more 
controversy, rather than answering the question of 
whether specific HPV infection also plays a role in the 
development of adenocarcinoma of the cervix. Molecular 
DNA hybridization techniques were used to detect HPV 
types prevalent in both adenocarcinoma and squamous 
cell carcinoma of the uterine cervix, which is the most 
common cancer in Indian women. 
Methods. Histologically confirmed, formaldehyde- 
fixed, paraffin-embedded tissue sections from 1 2  cases of 
adenocarcinoma and 30 cases of squamous cell carci- 
noma of the uterine cervix were analyzed retrospectively 
for the presence of HPV DNA types 6b, 11,16, and 18 by 
both Southern blot hybridization and in situ hybridiza- 
tion. 
Of 1 2  adenocarcinomas, 5 (41.67%) tumors 
were positive for HPV DNA. All five cases were positive 
for HPV 16, and two (16.6%) of these were hybridized 
again to the HPV 18-specific DNA probe. All tumors were 
negative for HPV 6b and 11. In addition, no biopsy speci- 
mens were positive after hybridization with a mixed 
probe of HPV 31, 33, 35, 39, and 45. These results were 
compared to those obtained for 30 squamous cell carci- 
nomas of the cervix. Although 20 (66%) were exclusively 
positive for HPV 16 and 6 (20%), more tumors were of 
HPV 16 related types as detected under nonstringent con- 
ditions of hybridization, only one (3%) was positive for 
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HPV 18. The results of in situ hybridization were found 
to be in good agreement with those of Southern blotting. 
HPV 16 is the type present almost ex- 
clusively in squamous cell carcinoma of Indian women. 
A higher frequency of HPV 16 in adenocarcinoma of In- 
dian women, in contrast to HPV 18, as reported from 
other regions, may be attributed to geographic variation 
rather than to histologic differences only, and both HPV 
16 and 18 may be present in adenocarcinoma of the uter- 
ine cervix. Cancer 1993; 72147-53. 
Conclusions. 
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The association of human papillomavirus (HPV) infec- 
tion with cervical carcinogenesis is well documented.'-' 
Distinct HPV DNA types, particularly HPV 16 and 
HPV 18, are demonstrated in more than 95% of inva- 
sive squamous cell carcinomas (SCC) of the uterine 
cervix. 3-8 
Invasive carcinomas of the uterine cervix mainly 
comprise three histologic subtypes, namely, SCC, ade- 
nocarcinoma (ADC), and adenosquamous carcinoma 
(ADSC). The occurrence of the latter two is relatively 
low, and the frequency varies between only 3% to 10% 
of all malignant cervical turn or^.^^'^ Unlike SCC, how- 
ever, the risk factors for ADC of the cervix are not well 
understood. HPV DNAs, particularly types 16 and 18, 
are detected frequently in high-grade cervical intra- 
epithelial neoplastic lesions that often arise adjacent to 
adenocarcinoma of the cervix." Recently, there have 
been several reports showing the presence of HPV 
DNA, predominantly HPV type 18, in ADC and ADSC 
of the This is in sharp contrast to invasive 
SCC, in which the incidence of HPV 16 is very 
high.4-7," The high prevalence of HPV 18 in ADC has 
been attributed mainly to histologic differences rather 
than to geographic ~ar ia t ion . '~ , '~  
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Table 1. Analysis of HPV DNA in Adenocarcinoma of the Uterine Cervix 
In situ hybridization Southern blot hybridization 
Slide no. Case no. HPV 16 HPV 18 H P V 6 + 1 1  HPV 16 HPV 18 HPV 6 + 11 
- - t - - 1 H-84/ 125 + 
2 H-82/117 - - - 
3 H-88/399 - 
4 H-88/334 + + + + 
5 H-88/237 - 
6 H-86/82E + 
7 H-88/369 - - - 
8 H-81/106 - 
9 H-84/320 + + + + 
10 H-88/420 - - - 
11 H-89/54 + 
12 H-84/107 - - - 
- - - 
- - - - - 
- - 
- - - - - 
~ - - + - 
- - - 
- - - - - 
- - 
- - - 
- - - - - 
- - - 
Total 5/12 (41.66%) 2/12 (16.66%) Nil 4/12 (33.33%) 2/12 (16.6%) Nil 
In India, cancer of the uterine cervix is the most 
common cancer in women, and more than 90,000 
women have this cancer annually. ’’-’’ The prevalence 
of HPV 16 and its related types was found to be very 
high (> 90%), whereas the frequency of HPV 18 and 
other types is extremely low or a b ~ e n t . ~  So far, how- 
ever, there have been no reports on HPV prevalence in 
ADC of Indian women. The current study therefore 
was carried out in 12 histologically confirmed cases of 
ADC of the cervix, using both in situ hybridization and 
Southern blotting techniques to detect different HPV 
types and to compare the results with those obtained 
for SCC of the uterine cervix. 
Materials and Methods 
Twelve histologically confirmed ADC and 30 SCC of 
the cervix were selected for retrospective analysis of 
HPV DNA sequences by both in situ hybridization and 
Southern blotting. These cases were diagnosed during 
regular screening for cervical carcinoma from 1988 to 
1990 at the Division of Cytopathology of our Institute. 
Biopsy specimens were obtained from gynaecological 
Table 2. Prevalence of HPV DNA in Adenocarcinoma of 
the Uterine Cervix 
Method HPV 16 HPV 18 HPV 6 + 11 Total HPV 
employed positivity positivity positivity positivity 
Tissue in situ 
hybridization 
(n = 12) 5 (41.6%) 2 (16.6%) Nil 7 (58.3%) 
hybridization 
(n = 12) 4 (33.3%) 2 (16.6%) Nil 6 (50%) 
Southern blot 
outpatient department (cancer clinic) of the Lok Nayak 
Jai Parkash Narayan (LNJPN) Hospital, New Delhi. 
Tissue sections from paraffin blocks were used for in 
situ hybridization as well as to extract DNA for South- 
ern blot hybridization. 
In Situ hybridization 
Formaldehyde-fixed, paraffin-embedded tissues were 
cut into 5-pm sections, mounted on slides that were 
prewashed in acid and sodium dodecyl sulfate, and 
coated with poly-L-lysine (Sigma Chemical Co., St. 
Louis, MO). After deparaffinization with xylene and 
dehydration through alcohol grades, sections were 
treated with proteinase K (100 pg/ml; Boehringer 
Mannheim, Germany) at 37°C for 30 minutes. The 
slides were then washed in phosphate-buffered saline 
(PBS; pH 7.2) three times for 5 minutes each, dehy- 
drated through alcohol grades, and air dried. The slides 
were desiccated at 4°C until use. 
Probe Preparation and Hybridization 
Molecularly cloned HPV 16,” 18,” 6b,23 and llZ4 
DNAs were the kind gift of Profs. H. zur Hausen, L. 
Gissmann and E. M. devilliers (Deutsches Krebsfors- 
chungszentrum, Heidelberg, Germany). The HPV plas- 
mids were purified by cesium chloride-ethidium bro- 
mide gradient centrifugation methods. The 8-kilobase 
(kb) viral inserts were isolated from the vector DNA by 
digestion with cloning enzyme, separated in agarose 
gel, and subsequently eluted in DEAE ion-exchange 
membrane (Serva 40362, Heidelberg, Germany). Vec- 
tor-free HPV DNAs were nick-translated with 3H- 
dCTP, 3H-dATP, and 3H-dTTP (specific activities: 66, 
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Table 3. Prevalence of HPV DNA in Squamous Cell Carcinoma of the Uterine Cervix 
Method HPV 16 HPV 18 HPV 6 + 11 HPV 16* Total HPV 
employed positivity positivity positivity positivity positivity 
Tissue in situ 
hybridization 
(n = 30) 19 (63.4%) 1 (3.3%) 1(3.3%) - 21 (70.0%)** 
Southern blot 
hybridization 
(n = 30) 20 (66.7%) 1 (3.3%) 1(3.3%) 6 (20.0%) 28 (93.4%) 
* Positivity under nonstringent hybridization conditions. 
** This excludes related HPV types because no in situ hybridization was done under nonstringent conditions (Tm 
-40°C). 
65, and 100 Ci/mmol, respectively; Amersham Interna- 
tional plc, Amersham, United Kingdom) to specific ac- 
tivities of not less than 1 X lo8 disintegration per min- 
ute/pg DNA. The hybridization mixture contained 
50% formamide, 10% W/v dextran sulfate, 10% (V/V) 
20X 3M sodium chloride plus 0.3M sodium citrate 
(SSC), 0.02% (W/V) Ficoll, 0.02% W/V bovine serum 
albumin (pentax fraction V), 0.02% W/V polyvinylpyr- 
olidone, 250 pg/ml RNA (4S), and the labeled HPV 
DNA probe. The hybridization solution with HPV 
probe was added to the tissue sections on slides pro- 
cessed earlier, and hybridization was carried out at 
42°C for 48 hours after denaturation at 90°C for 10 
minutes and chilling in ice-water for 5 minutes. After 
washings in 50% formamide in 2X SSC and 0.5X SSC 
H PV 
kb 1 6 1 8 1  2 3 4 5 6 7 8 9  kb 
23.1 - 
9.4 - 
6.6 - 
4.3 - - 2.8 
2.3 - 
2.0 - 
- 1.9 - 1.6 - 1.0 
- 0.5 
Figure 1. Southern blot hybridization analysis of HPV DNA 
sequences in ADC of the uterine cervix. Seven to 8 pm of cellular 
DNA were digested with (left) Bam HI and (right) Pst I, 
electrophoresed in 1 YO agarose gel, and hybridized with 32P-labeled 
HPV 16 DNA probe under stringent conditions (Tm -20°C and 
50% formamide). (Left) The results from nine specimens (lanes 1-9), 
of which four were positive (lanes 2, 5, 6, and 9), showing 8-kb 
bands for HPV 16. In the first two lanes, 10 pg of HPV 16 and 18 
DNA were used as positive controls, and there is no signal for HPV 
18 because the probe used was HPV 16. (Right) The characteristic 
Pst I cleavage pattern of HPV 16 is shown (arrows), and sizes are 
indicated in kilobases. 
solutions at 42°C for 5 minutes each, the slides were 
again washed twice in 0.5X SSC at room temperature, 
alcohol dehydrated, and air dried. The slides were then 
coated in the dark with Kodak NTB 2 nuclear track 
emulsion (Eastman Kodak, Rochester, NY) and exposed 
for 4 to 6 weeks at 4°C. After developingin D19b devel- 
oper, the slides were stained with hematoxylin and eo- 
sin and examined by oil immersion microscopy for the 
presence of silver grains over the cell nuclei. 
DNA Extraction and Southern Blotting 
DNA extraction was done as described earlier,25r26 with 
certain modifications. About 15 to 20 tissue sections 
from each of the formaldehyde-fixed paraffin blocks 
were placed in an Eppendorf tube. After deparaffiniza- 
tion in xylene and dehydration in absolute ethanol, the 
sections were rehydrated and washed three times in 
PBS. These tissue sections and biopsy samples of SCC, 
stored at -7O"C, were either homogenized in mortar 
and pestle with a small amount of sea sand and 0.5 ml 
of 1 X  TE (10 mmol/l Tris-HC1, and 1 mmol/l EDTA, 
pH 8.0), or minced with a fine blade in a Petri dish, and 
the tissue homogenate was transferred to a centrifuge 
tube containing lysis (3% SDS) buffer and proteinase K 
(100 pg/ml). The tubes were incubated at 37°C or 50°C 
overnight, and DNA was extracted using conventional 
phenol-chloroform methods. 
The purified DNA, amounting to about 7 to 8 pg, 
was cleaved with Bam HI (a single-cut restriction en- 
zyme for HPV; Boehringer Manheim) according to the 
manufacturer's protocol. One of the five positive sam- 
ples in which the yield of DNA was sufficient was also 
digested with a multicut enzyme, Pst 1 (Boehringer 
Manheim). Digested DNA was separated in 1% agarose 
gel electrophoresis and blotted onto Gene-Screen Plus 
membrane (NEN Research Products, Dupont, Boston, 
MA) as described by Southern," with some modifica- 
t i o n ~ . ~ , ~ '  Vector-free HPV inserts were nick-tran~lated~~ 
or rand~rn-primed~' with 32P-dTTP or 32P-dCTP (spe- 
cific activity, 3000-4000 Ci/mmol; Amersham UK, and 
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Figure 2. In situ hybridization of ADC tissue sections with 
radiolabeled HPV 16 and 18 DNA probes using the single-copy 
gene localization method. The presence of (top) HPV 16 and 
(bottom) HPV 18 in areas of well differentiated ADC (arrows) was 
shown by deposition of silver grains over the nuclei. Hybridization 
was done with 3H-labeled dTTP, dCTP, and dATP, with exposure 
at 4°C for 5 weeks after coating with Kodak NTB2 nuclear track 
emulsion. 
Bhabha Atomic Research Centre, Bombay, India) to a 
specific activity of more than 10' dpm/pg of DNA. 
Blots were hybridized with radiolabeled HPV 16, 18, 
6b, and 11 DNA under stringent (melting temperature 
-20°C) as well as nonstringent (melting temperature 
-40°C) conditions at 42°C (50% formamide) for 16 to 
18 hours. After washings, the filters were air dried and 
exposed to Kodak X-OMAT-AR x-ray film with intensi- 
fying screen at -70°C. 
Results 
HPV types 16, 18, 6b, and 11 DNAs were used as 
probes either individually or in combination to detect 
the type of HPV DNA sequence present in 12 pure 
ADC and 30 SCC of the uterine cervix. The results of in 
situ hybridization as well as Southern blot hybridiza- 
tion are presented in Tables 1 through 3. Using in situ 
hybridization, HPV 18 DNA was detected only in two 
cases, whereas HPV 16 DNA was found in five cases of 
ADC. The results of in situ hybridization were in good 
agreement with those of Southern blotting, except for 
one HPV 16 in situ-positive case that could not be de- 
tected by Southern blotting. This disparity between the 
two methods might be because of low copy of HPV 16 
DNA or an inadequate amount of cellular DNA used 
for Southern blot analysis. Figure 1 shows Southern 
blot hybridization analysis of nine ADC DNA samples. 
Lanes 2,5,6, and 9 are the four samples, each of which 
shows a single 8-kb band after digestion with a single- 
cut enzyme, Barn H1, for HPV 16. Figure 1 (right) 
shows a characteristic Pst 1 cleavage pattern of HPV 16 
(arrows) for the same sample shown on lane 2 in Figure 
1 (left). 
Under nonstringent conditions of hybridization 
(Tm -40°C and 20% formamide) using HPV 16 DNA 
as probe, no positive tumor was found of the seven 
negative ADC; in addition, none of these were found 
positive for HPV 16 or 18 by polymerase chain reaction 
(data not given). The two HPV 18-positive tumors also 
contained HPV 16 DNA. Figure 2 shows HPV positivity 
by in situ hybridization of histologic sections of ADC of 
the cervix. In the current study, the frequency of HPV 
16 positivity was found to be 41.67% (5/12), which is 
higher than the frequency of HPV 18 positivity 
(16.6770, 2/12) in ADC of the uterine cervix. The dif- 
ference, however, was found to be statistically insignifi- 
cant because of the small number of cases analyzed. No 
ADC was found to be positive for HPV 6b and 11 DNA 
by either in situ or Southern blot hybridization. Also, no 
positive signal was obtained when hybridization was 
carried out using a mixed probe of other prevalent geni- 
tal HPV types (31, 33, 35, 39 and 45). 
The results obtained in 30 SCC samples by both in 
situ and Southern blot hybridization are presented in 
Table 3. Representative in situ hybridization photomi- 
crographs (Fig. 3) show clear positivity for HPV 16, as 
revealed by high grain concentrations in squamous cell 
nuclei. These samples were used again for Southern 
blot hybridization (Fig. 4), which showed authentic Pst 
I fragments (arrows) for HPV 16. There also was good 
correlation between the results obtained by the above 
two techniques. With in situ hybridization, 63% (19/ 
30) were positive for HPV 16, whereas 66% (20/30) 
were positive by Southern blotting. Total positivity for 
HPV was 93%, which includes nonstringently (Tm 
-40°C) detected related HPV types (20%). Other HPV 
types were completely absent, except one specimen 
each positive for HPV 18 (3.3%) and HPV 11 (3.3%). 
Because no nonstringent in situ hybridization could be 
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Figure 3. In situ hybridization of SCC 
tissue sections with 3H-labeled HPV 
16 DNA probe. High grain 
concentrations can be seen in most 
of the cell nuclei under (left) low 
(hematoxylene and eosin, original 
magnification X100) as well as (right) 
high (hematoxylene and eosin, 
original magnification X400) 
magnification. 
done, no related or unknown HPV type was detected 
by this technique. 
Discussion 
Squamous cell carcinoma is the predominant type of 
cancer of the uterine cervix, and HPV 16 is the most 
common type of HPV DNA in these tumors, being de- 
tected in 80% to 90% of cases, whereas HPV 18 has 
been found only in 1% to 25% of cervical carci- 
no ma^.'+^,^^ In c ontrast, several reports demonstrate 
that HPV 18 is the most prevalent and HPV 16 is less 
frequent in ADC and ADSC of the uterine 
The current retrospective study in Indian women 
demonstrates a higher frequency of HPV 16 rather than 
HPV 18 in ADC, as revealed by both in situ and South- 
ern blot hybridization (Tables 1, 2). This is in good 
agreement with the recent report of Giffin et al, who 
used polymerase chain rea~tion.~’ Of 12 cases, 5 
(41.67%) were positive for HPV 16, whereas only 2 
(16.67%) contained HPV 18 DNA. Again, these two 
cases with HPV 18 also contained HPV 16 DNA. This 
may raise the question that this HPV 16 DNA might 
have been derived from adjacent neoplastic squamous 
epithelium. Such an assumption is not warranted, be- 
cause all cases were histologically confirmed as pure 
ADC, and there was no sign of neoplastic squamous 
epithelium in the sections stained with hematoxylin 
and eosin (Fig. 2), which were examined thoroughly by 
cytopathologists before being selected for HPV DNA 
analysis. Nevertheless, presence of both HPV 16 and 
HPV 18 in ADC of the cervix has been reported re- 
~ e n t 1 y . l ~ ~ ~ ~  The existence of HPV 16, although in low 
frequency, already has been demonstrated in ADC of 
the cervix by several earlier  author^.'^-'^,^^ In sharp 
contrast to findings from other regions, the high fre- 
quency of HPV 16 in ADC of the cervix in Indian 
women may be attributed to geographic variation 
H PV 
kb 111618 1 2  3 4 5 6 7 8  9 10 
23.1 - 
9.4 - 
6.6 - 
4.3 - 
2.3 - 
2.0 - 
0.5 - 
Figure 4. Southern blot hybridization of Pst I-digested DNA samples 
of SCC. Arrows indicate authentic Pst I-specific bands for HPV 16. 
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rather than solely to histologic differences. This argu- 
ment gains support from the recent United Kingdom 
study using polymerase chain reaction that also demon- 
strated a higher frequency (4/16) of HPV 16 as opposed 
to HPV 18 (1/16) in ADC of the cervix.32 Furthermore, 
the frequency of HPV 18 in SCC in Indian women was 
found to be extremely low (3%), whereas the frequency 
of HPV 16 was more than 90% (Tables 2, 3).4,5 Using 
biotinylated probes in in situ hybridization, Young et al. 
have shown a complete absence of HPV in ADC from 
other parts of the United Kingdom.35 These observa- 
tions strongly suggest that the prevalences of HPV 
types in ADC of the cervix vary in different geographic 
regions, just as has been reported for SCCe3 The fre- 
quent coexistence of adenomatous lesions with squa- 
mous lesions” suggests that both squamous and col- 
umnar neoplasm may originate from the same precur- 
sor ”reserve cells.”35 Depending on the carcinogenic 
stimulus (e.g, viral infection) and the type of viral re- 
ceptors present, the cervical cells may transform into 
neoplasia of different histologic types such as SCC, 
ADSC, and ADC.” Alternatively, if HPV infection is 
responsible for transformation, it is possible that there 
may be subclinical benign lesions in endocervical cells 
that give rise to SCC through cervical intraepithelial 
ne0p1asia.l~ There is good agreement, however, be- 
tween the results with Southern blotting and in situ 
hybridization. To resolve the issue of which HPV type 
is more prevalent in ADC, more studies on the preva- 
lence of HPV in cervical ADC are needed from different 
geographic regions. 
Nevertheless, the presence of both HPV types 16 
and 18 DNA sequences in ADC confirms others find- 
ings and suggest that both of these “high-risk’ HPV 
types may coexist in ADC of the uterine cervix. 
References 
1.  
2. 
3. 
4. 
5 .  
zur Hausen H. Papillomaviruses as carcinomaviruses. In: Klein 
G, editor. Advances in viral oncology. vol. 8. New York: Raven 
Press, 1989:l-26. 
Pfister H. Human papillomavirus and genital cancer. Adv Cancer 
Res 1987; 48:113-47. 
Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papilloma- 
virus DNA from a cervical carcinoma and its prevalence in 
cancer biopsy samples from different geographic regions. Proc 
Das BC, Sehgal A, Murthy NS, Gopalkrishna V, Sharma JK, Das 
DK, et al. Human papillomavirus and cervical cancer in Indian 
women. Lancer 1989; 2:1271. 
Das BC, Sharma JK, Gopalkrishna V, Das DK, Singh V, Giss- 
mann L, et al. A high frequency of human papillomavirus DNA 
sequences in cervical carcinomas of Indian women as revealed 
by Southern blot hybridization and polymerase chain reaction. 1 
Med Virol 1992; 36:239-45. 
Natl Acad Sci USA 1983; 80~3812-5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
Gissmann L, Durst M, Oltersdorf T, von Knebel Doeberitz M. 
Human papillomaviruses and cervical cancer. Cancer Cells 1987; 
Pfister H. Relationship of papillomaviruses to anogenital cancer. 
Obstet Gynecol Clin North A m  1987; 14:329-469. 
Meanwell CA, Cox MF, Blackledge G, Maitland NJ. HPV 16 
DNA in normal and malignant cervical epithelium: implications 
for the aetiology and behaviour of cervical neoplasia. Lancet i 
Twiggs LB, Okagaki T, Adcock LL, Leung BS, Prema KA, Potish 
RA. Adenocarcinoma of the cervix: histologic variation, prob- 
lems in diagnosis, and special considerations of biology. In: Kuri- 
hara S, Noda K, Tenjin Y, Kubo H, Kasamatsu T, editors. Cervi- 
cal pathology and colposcopy. Amsterdam: Elsevier Scientific 
Publishers BV, 1985:61-8. 
Shingleton HM, Orr JLU. Cancer of the cervix: diagnosis and 
treatment. In: Monaghan JM, editor. Clinical obstetrics and gyn- 
aecology. New York: Churchill-Livingston, 1987; 1-315. 
Maier RC, Noris HJ. Co-existence of cervical intraepithelial neo- 
plasia with primary adenocarcinoma of the endocervix. Obstet 
Gynecol 1980; 56:361-4. 
Smotkin D, Berek JS, Hacker NF, Major FJ, Wettstein FO. Hu- 
man papillomavirus deoxyribonucleic acid in adenocarcinoma 
and adeno-squamous carcinoma of the uterine cervix. Obstet 
Gynecol 1980; 68:241-4. 
Wilczynski SP, Walker J, Shu-yuan L, Suzanne B, Michhel B. 
Adenocarcinoma of the cervix associated with human papillo- 
mavirus. Cancer 1988; 62:1331-6. 
Tase T, Okagaki T, Clark BA, Manias DA, Obstrow RS, Twiggs 
LB, et al. Human papillomavirus types and localization in 
adeno-carcinoma and adenosquamous carcinoma of the uterine 
cervix: a study by in situ DNA hybridization. Cancer Res 1988; 
Tase T, Sat0 S, Wada Y, Yajima A, Okagaki T. Prevalence of 
human papillomavirus Type 18 DNA in adenocarcinoma and 
adenosquamous carcinoma of the uterine cervix occurring in Ja- 
pan. Tohoku J Exp  Med 1988; 156:47-52. 
Hrding U, Teglbjaerg CS, Visfeldt J, Bock JE. Human papilloma- 
virus types 16 and 18 in adenocarcinoma of the uterine cervix. 
Gynecol Oncol 1992; 46:313-6. 
Gariglio P, Ocadiz R, Sauceda R. Human papillomavirus DNA 
sequences and c-myc oncogene alterations in uterine cervix carci- 
noma. Cancer Cells 1987; 5:343. 
Luthra UK, Prabhakar AK, Seth P, Agarwal SS, Murthy NS, 
Bhatnagar P, et al. Natural history of precancerous and cancer- 
ous lesions of uterine cervix. Acta Cytol 1987; 31:226-36. 
World Health Organization. Control of cancer cervix uteri. WHO 
Bull 1986; 64:607. 
Murthy NS, Sehgal A, Satyanarayana L, Das DK, Singh V, Das 
BC, et al. Risk factors related to biological behaviour of precan- 
cerous lesions of the uterine cervix. Br J Cancer 1990; 61:732-6. 
Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papilloma- 
virus DNA from a cervical carcinoma and its prevalence in 
cancer biopsy samples from different geographic regions. Proc 
Natl Acad Sci USA 1983; 80:3812-5. 
Boshart ML, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen 
W, zur Hausen H. A new type of papillomavirus DNA: its preva- 
lence in cancer biopsies and cell-lines derived from cervical 
cancer. EMBO 1 1984; 3:1151-7. 
de Villiers EM, Gissmann L, zur Hausen H. Molecular cloning of 
viral DNA from human genital warts. 1 Virol 1981; 40:932-5. 
Gissmann L, Diehl V, Schultz-Coulon HJ, zur Hausen H. Molec- 
ular cloning and characterization of human papillomavirus 
5~275-80. 
1987; 31703-707. 
48~993-8. 
HPV in Adenocarcinoma of the Cervix/Das e t  al .  153 
25. 
26. 
27. 
28. 
29. 
DNA derived from a laryngeal papilloma. J Virol 1982; 44:393- 
400. 
Lancaster WD, Kurman RJ, Sanz LC, Perry S, Jenson AB. Hu- 
man papillomavirus: detection of viral DNA sequences and evi- 
dence for molecular heterogenicity in metaplasias and dyspla- 
sias of the uterine cervix. Intervirology 1983;20:202-12. 
Sharma BK, Luthra UK, Shah KV. Identification of human pa- 
pillomavirus in paraffin embedded cervical pathological tissues 
from Indian women by polymerase chain reaction. Ann Biol Clin 
1991; 49:93-5. 
Southern EM. Detection of specific sequences among DNA frag- 
ments separated by gel electrophoresis. J Mol Biol 1975; 98:503- 
17. 
Das BC, Sharma JK, Gopalkrishna V, Luthra UK. Analysis by 
polymerase chain reaction of the physical state of human papil- 
lomavirus type 16 in cervical preneoplastic and neoplastic le- 
sions. J Gen Virol 1992; 73:2327-36. 
Rigby PWJ, Dickdes C, Beg P. Labelling deoxyribonucleic acid to 
high specific activity by nick-translation with DNA polymerase 
I. ] Mol Biol 1977; 113:237-42. 
30. Feibnerg AP, Vogelstein 8.  A technique for radiolabelling DNA 
restriction endonuclease fragments to high specific activity. Anat 
Biochem 1983; 132:6-11. 
31. Griffin NR, Dockey D, Lewis FA, Wells M. Demonstration of 
low frequency of human papillomavirus DNA in cervical adeno- 
carcinoma and in-situ hybridization. Int 1 Gynecol Pathol 1991; 
32. Leninen A, Paavonen J, Vesterinen E, Wahlstorm T, Rantala I, 
Lehtinen M. Human papillomavirus types 16 and 18 in adeno- 
carcinoma of the uterine cervix. Am J CIin Pathol 1991; 95:647- 
52. 
33. Wolber RA, Clement PB. In situ DNA hybridization of cervical 
small cell carcinoma and adenocarcinoma using biotin-labeled 
human papillomavirus probes. Modern Pathology 1991; 4:96- 
100. 
34. Young FI, Ward LM, Brown LJR. Absence of human papilloma- 
virus in cervical adenocarcinoma determined by in situ hybrid- 
ization. ] Clin Pathol 1991; 44:340-1. 
35. Christopherson WM, Nealson N, Grayla Sr. Noninvasive pre- 
cursor lesions of adenocarcinoma and mixed adenosquamous 
carcinoma of the cervix uteri. Cancer 1979; 44:975-83. 
10:36-43. 
